Dr. Om Prakash Manchanda
#279Managing Director
59
Age
35y
Exp
20y
Tenure
6/10
Risk
🎓 B.Tech Veterinary Sciences · Haryana Agricultural University
📜 MBA · Indian Institute of Management, Ahmedabad
🏛️ IIM
CompensationTBP
Personality
6
Open
7
Cons
5
Extr
5
Agre
3
Neur
Dr Lal Pathlabs
Healthcare · Mid Cap
Mature Stable · Performance-Driven
About
Dr. Om Prakash Manchanda is the Managing Director of Dr Lal Pathlabs, a Mid Cap company in the Healthcare sector with a market cap of ₹23K Cr. A Transformational leader with 35 years of experience, he is known for data-driven decision-making and aggressive acquirer strategy. He has been instrumental in institutionalizing a fragmented pathology market through aggressive hub-and-spoke expansion strategies.
FAQ
What is Dr. Om Prakash Manchanda's leadership style?
Dr. Om Prakash Manchanda is classified as a Transformational leader. He is data-driven in decision-making, with a empire expander motivation and steady-marathon pace of execution.
What is Dr. Om Prakash Manchanda's educational background?
Dr. Om Prakash Manchanda holds a B.Tech Veterinary Sciences from Haryana Agricultural University and a MBA from Indian Institute of Management, Ahmedabad.
Who is the CEO of Dr Lal Pathlabs?
Dr. Om Prakash Manchanda is the Managing Director of Dr Lal Pathlabs. He has been with the company for 20 years and in the current role for 5 years.
Leadership DNA
ArchetypeTransformational
MotivationEmpire Expander
CrisisRevenue Hunter
DecisionData-Driven
GrowthAggressive Acquirer
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerMass-Consumer
EmployerSteady Employer
BrandTrusted
FocusMarket Expansion
OrientationSector Adjacent
Leadership Evidence
“He has been instrumental in institutionalizing a fragmented pathology market through aggressive hub-and-spoke expansion strategies.”
⚡ Crisis●●●●○
During the COVID-19 pandemic, he aggressively scaled up testing capacity and home collection services to capture market share while competitors struggled with logistics.
🎯 Motivation●●●●○
He has led Dr Lal Pathlabs through a strategy of aggressive geographic expansion and consolidation of the fragmented diagnostics market via strategic acquisitions.
👥 People●●●●○
He is widely recognized for his data-driven management style, utilizing granular operational metrics and KPIs to optimize lab efficiency and turnaround times.
📈 Growth●●●●●
He has consistently utilized inorganic growth to expand the company's footprint, most notably the acquisition of Suburban Diagnostics in 2021.
💡 Innovation●●●●○
The company excels at scaling a hub-and-spoke diagnostic model and adopting standardized testing technologies rather than inventing new medical diagnostic categories.
🏃 Pace●●●●○
The company follows a methodical, predictable expansion strategy of acquiring regional labs and expanding its network footprint over several decades.
🌱 Purpose●●●○○
The company emphasizes 'delivering accurate reports' as a core healthcare service while maintaining standard CSR initiatives focused on community health awareness.
🏷️ Brand●●●●●
The brand is synonymous with reliability and clinical accuracy, positioning itself as the dependable choice for diagnostic testing in the Indian healthcare market.
🤝 Customer●●●●●
The company operates a vast B2C network of diagnostic centers and home-collection services targeting the general public directly.
💼 Employer●●●○○
The company is recognized for a stable, process-driven work environment focused on operational consistency across its large network of laboratories.
📋 Mandate
To maintain market leadership amidst intense competition, the focus must shift to maximizing service reliability and customer experience.
🏢 Culture●●●●○
High focus on scale, diagnostic efficiency, and aggressive growth, balancing medical rigour with modern corporate sales performance targets.
Financials
Revenue FY25₹2K Cr
PAT FY25₹487 Cr
Rev CAGR 5Y5.6%
OPM22.8%
NPM19.8%
ROE22.4%
ROCE24.2%
P/E42.9
Fwd P/E38.3
P/B9.5
D/E6.4
Promoter56%
Institutional33.3%
Mkt Cap₹23K Cr
Compensation
To Be Published
Data being verified from audited reports
